Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1284-1294

  Hargreaves, Andrew C ^a,b   Gunthorpe, Martin J ^c   Taylor, Colin W ^b   Lummis, Sarah C R ^b,c  

^a Dept Anat Sch Med Sci U   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; CALCIUM CHANNEL; DILTIAZEM; GRANISETRON; NIMODIPINE; SEROTONIN 3 RECEPTOR; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; STEREOCHEMISTRY; TISSUE DISTRIBUTION;

BIGUANIDES; BINDING, COMPETITIVE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; ELECTROPHYSIOLOGY; FURA-2; GRANISETRON; HUMANS; KIDNEY; KINETICS; MICROSCOPY, VIDEO; NEUROBLASTOMA; NIMODIPINE; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TRITIUM; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0029831552     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Betz, H. Ligand-gated ion channels in the brain: the amino acid receptor superfamily. Neuron 5:383-392 (1990).
2. 3 receptor. J. Neurochem. 64:1401-1405 (1995).
3. 3 receptors provides new insights into their maturation and structure. J. Biol. Chem. 270:6056-6061 (1995).
4. Orteils, M. O., and G. G. Lunt. Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 18:121-127 (1995).
5. 3 receptor, a serotonin-gated ion channel. Science (Washington D. C.) 254:432-437 (1991).
6. Boess, F. G., and I. L. Martin. Molecular biology of 5-HT receptors. Neuropharmacology 33:275-317 (1994).
7. 3 receptor gene and functional expression of two splice variants. Mol. Brain Res. 26:233-241 (1994).
8. 3 receptor A subunit. Eur. J. Pharmacol. 245:187-192 (1993).
9. 3 receptor gene and assignment to human chromosome 11. FEBS Lett. 339:302-306 (1994).
10. 3 receptor: heterogeneity in distribution and function among species. Mol. Pharmacol. 48:407-416 (1995).
11. 3 receptor splice variants in the rat. J. Neurochem. 65:475-483 (1995).
12. 3 receptor-A mRNA in NG108-15 cells. J. Neurochem. 65:1917-1925 (1995).
13. 3 R-A subunit expressed in Xenopus laevis oocyte. Neuropharmacology 33:473-482 (1994).
14. 3 receptors from NCB20 and NG108-15 cell lines. Br. J. Pharmacol. 112:316P (1994).
15. 3 receptor antagonists: a critical update on therapeutic potential. Trends Pharmacol. Sci. 14:265-270 (1993).
16. 3 receptor-induced currents in NIE-115 neuroblastoma cells. Eur. J. Pharmacol. 151:491-495 (1988).
17. 3 receptors in intact N1E-115 neuroblastoma cells. Eur. J. Pharmacol. 189:223-227 (1990).
18. 3 receptors from N1E-115 neuroblastoma cells. Mol. Pharmacol. 41:18-23 (1992).
19. 3 receptors. Trends Pharmacol. Sci. 13:391-397 (1992).
20. Yang, J. Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells. J. Gen. Physiol. 96:1177-1198 (1990).
21. 3 receptor channels in dissociated rat superior cervical ganglion neurones. J. Physiol. 448:237-256 (1992).
22. 3 receptor channel. Annu. Rev. Physiol. 57:447-468 (1995).
23. 2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors. Mol. Pharmacol. 46:1120-1128 (1994).
24. 3 receptors in N1E-115 neuroblastoma cells. Br. J. Pharmacol. 104:536-540 (1991).
25. Bradford, M. M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
26. Pérez-García, M. T., T. J. Kamp, and Marbán, E. Functional properties of cardiac L-type calcium channels transiently expressed in HEK293 cells. J. Gen. Physiol. 105:289-305 (1995).
27. Williams, M. E., P. F. Brust, D. H. Feldman, S. Patthi, S. Simerson, A. Maroufi, A. F. McCue, G. Veliçelebi, S. B. Ellis, and M. M. Harpold. Structure and functional expression of an ω-conotoxin-sensitive N-type calcium channel. Science (Washington D. C.) 257:389-395 (1992).
28. Spedding, M., and R. Paoletti. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol. Rev. 44: 363-376 (1992).
29. Freckenstein, A. Calcium Antagonism in Heart and Smooth Muscle: Experimental Facts and Therapeutic Prospects. John Wiley and Sons, New York, 339 (1983).
30. 2+ channels. Nature (Lond.) 303:535-537 (1983).
31. Wang, R., E. Karpinski, L. Wu, and P. K. T. Pang. Flunarizine selectively blocks transient calcium channel currents in N1E-115 cells. J. Pharmacol. Exp. Ther. 254:1006-1011 (1990).
32. Triggle, D. J., and R. A. Janis. Calcium channel ligands. Annu. Rev. Pharmacol. Toxicol. 27:347-369 (1987).
33. 2+ channel antagonists. Trends Pharmacol. Sci. 13:256-262 (1992).
34. 2+ channel interaction. Trends Pharmacol Sci. 11:38-44 (1990).
35. Skeen, G. A., R. E. Twyman, and H. S. White. The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol. Pharmacol. 44:443-450 (1993).
36. Skeen, G. A., H. S. White, and R. E. Twyman. The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel. J. Pharmacol. Exp. Ther. 271:30-38 (1994).
37. Collingridge, G. L., and R. A. J. Lester. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev. 40:143-210 (1989).
38. 3H]MK-801 binding to mouse brain sections. Eur. J. Pharmacol. 269:325-330 (1994).
39. Parks, T. N., L. D. Artman, N. Alasti, and E. F. Nemeth. Modulation of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured cerebellar granule cells. Brain Res. 552:12-22 (1991).
40. López, M. G., R. I. Fonteríz, L. Gandía, M. de la Fuente, M. Villarroya, J. García-Sancho, and A. G. García. The nicotinic acetylcholine receptor of bovine chromaffin cell, a new target for dihydropyridines. Eur. J. Pharmacol. 247:199-207 (1993).
41. + channel cloned from human heart. Mol. Pharmacol. 44:642-648 (1993).
42. Koch, K.-W., and U. B. Kaupp. Cyclic GMP directly regulates a cation conductance in membranes of bovine rods by a cooperative mechanism. J. Biol. Chem. 260:6788-6800 (1985).
43. Nowycky, M. C., A. P. Fox, and R. W. Tsien. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature (Lond.) 316:440-443 (1985).
44. Nilius, B., P. Hess, J. B. Lansman, and R. W. Tsien. A novel type of cardiac calcium channel in ventricular cells. Nature (Lond.) 316:443-446 (1985).
45. Fox, A. P., M. C. Nowycky, and R. W. Tsien. Single channel recordings of three types of calcium channel in chick sensory neurones. J. Physiol. 394:173-200 (1987).
46. 2 receptors and GABA uptake sites. Trends Pharmacol. Sci. 8:200-201 (1987).
47. Hille, B. Ionic Channels of Excitable Membranes. 2nd Ed. Sinauer Associates, Sunderland, MA, 607 (1992).
48. Clapham, D. E., and E. Neher. Substance P reduces acetylcholine-induced currents in isolated bovine chromaffin cells. J. Physiol. 347:255-277 (1984).
49. Singh, L., A. E. Donald, A. C. Foster, P. H. Hutson, L. L. Iversen, S. D. Iversen, J. A. Kemp, P. D. Leeson, G. R. Marshall, R. J. Oles, T. Priestley, L Thorn, M. D. Tricklebank, C. A. Vass, and B. J. Williams. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-d-aspartate receptor antagonist, but (-)-HA-966 is a potent γ-butyrolactone-like sedative. Proc. Natl. Acad. Sci. USA 87:347-351 (1990).
50. Danysz, W., E. Fadda, J. T. Wroblewski, and E. Costa. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors. Mol. Pharmacol. 36:912-916 (1989).
51. Yakel, J. L., A. Lagrutta, J. P. Adelman, and R. A. North. Single amino acid substitution affects desensitization of the 5-hydroxytryptamine type 3 receptor expressed in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 90: 5030-5033 (1993).
52. 3 receptors suggest new treatments for psychoses and drug addiction. Trends Pharmacol. Sci. 10:127-129 (1989).
53. 2+ channel. Soc. Neurosci Abstr. 21:58 (1995).